Acute respiratory distress syndrome causes: Difference between revisions
Gerald Chi- (talk | contribs) m (→Common Causes) |
|||
(35 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute respiratory distress syndrome}} | {{Acute respiratory distress syndrome}} | ||
{{CMG}}; {{AE}} {{AO}} | {{CMG}}; {{AE}} {{AO}}, {{BShaller}} | ||
==Overview== | ==Overview== | ||
ARDS may be caused by either direct or indirect insults to the lung. Common causes of ARDS include [[pneumonia]], [[sepsis]], [[aspiration pneumonia|aspiration of gastric contents]], and [[transfusion-related acute lung injury|transfusion-related acute lung injury (TRALI)]]. | |||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening | ARDS is a life-threatening condition and must be treated as such irrespective of the causes. Life-threatening conditions may result in death or permanent disability within 24 hours if left untreated. | ||
===Common Causes=== | ===Common Causes=== | ||
* [[ | ARDS may occur as the result of either a direct or indirect insult to the lungs:<ref name="pmid7091520">{{cite journal| author=Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ| title=Clinical predictors of the adult respiratory distress syndrome. | journal=Am J Surg | year= 1982 | volume= 144 | issue= 1 | pages= 124-30 | pmid=7091520 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7091520 }} </ref><ref>The ARDS Definition Task Force*. “Acute Respiratory Distress Syndrome: The Berlin Definition.” JAMA 307, no. 23 (June 20, 2012): 2526–33. doi:10.1001/jama.2012.5669.</ref><ref>Wheeler, Arthur P., and Gordon R. Bernard. “Acute Lung Injury and the Acute Respiratory Distress Syndrome: A Clinical Review.” Lancet (London, England) 369, no. 9572 (May 5, 2007): 1553–64. doi:10.1016/S0140-6736(07)60604-7.</ref><ref>Sweeney, Rob Mac, and Daniel F. McAuley. “Acute Respiratory Distress Syndrome.” Lancet (London, England), April 28, 2016. doi:10.1016/S0140-6736(16)00578-X.</ref><ref>Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Baird, D. J. Eberle, T. L. Petty, and T. M. Hyers. “Adult Respiratory Distress Syndrome: Risk with Common Predispositions.” Annals of Internal Medicine 98, no. 5 Pt 1 (May 1983): 593–97.</ref> | ||
* [[ | |||
* [[ | * '''Direct insult''' | ||
* [[ | :* [[Pneumonia]] (bacterial, viral, fungal, or parasitic) | ||
* [[ | :* [[Aspiration pneumonia|Aspiration of of gastric contents]] | ||
* [[ | :* [[Acute inhalation injury|Inhalational injury]] (e.g., [[smoke inhalation]], toxic gas inhalation) | ||
* [[ | :* [[Fat embolism]] | ||
* [[ | :* [[Amniotic fluid embolism]] | ||
* [[ | :* [[Drowning|Drowning]] | ||
:* [[Pulmonary contusion]] | |||
:* [[Pulmonary hemorrhage|Alveolar hemorrhage]] | |||
:* [[Reperfusion]] ([[Thoracentesis|pleural effusion drainage]], [[embolectomy]]) | |||
:* [[Lung transplantation]] | |||
:* [[Ventilator-associated lung injury]] | |||
* '''Indirect insult''': | |||
:* Severe [[sepsis]] | |||
:* Major [[trauma]] (e.g., [[head trauma]], [[polytrauma]]) | |||
:* Multiple [[transfusion]]s or [[TRALI|transfusion-associated acute lung injury (TRALI)]] | |||
:* [[Drug overdose]] (e.g., [[acetylsalicylic acid]] overdose, [[heroin]] overdose) | |||
:* [[Pancreatitis]] | |||
:* Severe [[burns]] | |||
:* [[Shock]] | |||
:* [[Cardiopulmonary bypass]] | |||
:* [[Disseminated intravascular coagulation]] | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
Line 27: | Line 42: | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Mercury poisoning|Mercury inhalation]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 35: | Line 50: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Stevens-Johnson syndrome]], [[toxic epidermal necrolysis]]<ref name="pmid23989174">{{cite journal| author=de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Van Nhieu JT, Duong TA, Chosidow O et al.| title=Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. | journal=Crit Care Med | year= 2014 | volume= 42 | issue= 1 | pages= 118-28 | pmid=23989174 | doi=10.1097/CCM.0b013e31829eb94f | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23989174 }} </ref> | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Acetylsalicylic acid]], [[ado-trastuzumab emtansine]], [[afatinib]], [[amiodarone]], [[crizotinib]], [[cytarabine]], [[cytomegalovirus immune globulin]], [[docetaxel]], [[filgrastim]], [[Gonadotropin preparations|follitropin]], [[gemcitabine]], [[mitomycin]], [[nitrofurantoin]], [[sorafenib]], [[tbo-filgrastim]], [[urofollitropin]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 51: | Line 66: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Environmental''' | | '''Environmental''' | ||
|bgcolor="Beige"| [[Eosinophilic pneumonia|Acute eosinophilic pneumonia]], [[ | |bgcolor="Beige"| [[Eosinophilic pneumonia|Acute eosinophilic pneumonia]], [[Acute inhalation injury|inhalation injury]], [[drowning|near-drowning]], [[Burn|surface burns]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Aspiration pneumonia|Aspiration of gastric contents]], [[pancreatitis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 63: | Line 78: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Bone marrow transplantation]], [[transfusion-related acute lung injury|massive blood transfusion]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| [[Bone marrow transplantation]], [[cardiopulmonary bypass]], [[massive blood transfusion]] | |bgcolor="Beige"| [[Bone marrow transplantation]], [[cardiopulmonary bypass]], [[transfusion-related acute lung injury|massive blood transfusion]], [[oxygen toxicity]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| [[Eosinophilic pneumonia|Acute eosinophilic pneumonia]], [[ehrlichiosis ]], [[leptospirosis]], [[malaria]], [[miliary tuberculosis]], [[pneumonia]], [[sepsis]], [[severe acute respiratory syndrome]] | |bgcolor="Beige"| [[Eosinophilic pneumonia|Acute eosinophilic pneumonia]], [[ehrlichiosis]], [[leptospirosis]], [[malaria]], [[miliary tuberculosis]], [[pneumonia|pneumonia (bacterial, viral, fungal, or parasitic)]], [[sepsis]], [[severe acute respiratory syndrome|severe acute respiratory syndrome (SARS)]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Fat embolism]], [[polytrauma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Traumatic brain injury|Traumatic brain injury (TBI)]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 99: | Line 114: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| [[Acetylsalicylic acid]], [[heroin]], [[naloxone]] | |bgcolor="Beige"| [[Acetylsalicylic acid]], [[heroin]], [[naloxone]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 107: | Line 122: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| [[Eosinophilic pneumonia|Acute eosinophilic pneumonia]], [[Chemical pneumonitis| | |bgcolor="Beige"| [[Eosinophilic pneumonia|Acute eosinophilic pneumonia]], [[Chemical pneumonitis|aspiration of gastric contents]], [[cryptogenic organizing pneumonia|Cryptogenic organizing pneumonia (COP)]], [[decompression sickness]], [[fat embolism]], [[lung transplantation]], [[pneumonia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 123: | Line 138: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| [[Pulmonary contusion]], [[Physical trauma|severe trauma]] | |bgcolor="Beige"| [[Pulmonary contusion]], [[polytrauma]], [[Physical trauma|severe trauma]], [[Traumatic brain injury|traumatic brain injury (TBI)]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 138: | Line 153: | ||
{{col-begin|width=80%}} | {{col-begin|width=80%}} | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Acetylsalicylic acid]] | |||
*[[Ado-trastuzumab emtansine]] | *[[Ado-trastuzumab emtansine]] | ||
*[[Eosinophilic pneumonia|Acute eosinophilic pneumonia]] | *[[Eosinophilic pneumonia|Acute eosinophilic pneumonia]] | ||
*[[Afatinib]] | |||
*[[Amiodarone]] | |||
*[[Amniotic fluid embolism]] | *[[Amniotic fluid embolism]] | ||
*[[Anaphylaxis]] | *[[Anaphylaxis]] | ||
Line 145: | Line 163: | ||
*[[Bone marrow transplantation]] | *[[Bone marrow transplantation]] | ||
*[[Cardiopulmonary bypass]] | *[[Cardiopulmonary bypass]] | ||
*[[Cryptogenic organizing | *[[Crizotinib]] | ||
*[[Cryptogenic organizing pneumonia|Cryptogenic organizing pneumonia (COP)]] | |||
*[[Cytarabine]] | *[[Cytarabine]] | ||
*[[ | *[[Cytomegalovirus immune globulin]] | ||
*[[Ehrlichiosis ]] | *[[Docetaxel]] | ||
*[[Ehrlichiosis]] | |||
*[[Fat embolism]] | *[[Fat embolism]] | ||
*[[Filgastrim]] | *[[Filgastrim]] | ||
*[[ | *[[Gonadotropin preparations|Follitropin]] | ||
*[[Gemcitabine]] | |||
*[[Heroin|Heroin overdose]] | *[[Heroin|Heroin overdose]] | ||
*[[Smoke inhalation|Inhalation injury]] | *[[Smoke inhalation|Inhalation injury]] | ||
Line 160: | Line 181: | ||
*[[Miliary tuberculosis]] | *[[Miliary tuberculosis]] | ||
*[[Mitomycin]] | *[[Mitomycin]] | ||
*[[Massive blood transfusion]] | *[[Transfusion-related acute lung injury|Massive blood transfusion]] | ||
*[[Naloxone|Naloxone overdose]] | *[[Naloxone|Naloxone overdose]] | ||
*[[Near-drowning]] | *[[Drowning|Near-drowning]] | ||
*[[Nitrofurantoin]] | |||
*[[Oxygen toxicity]] | |||
*[[Pancreatitis]] | *[[Pancreatitis]] | ||
*[[Pneumonia]] | *[[Pneumonia]] | ||
*[[Polytrauma]] | |||
*[[Pulmonary contusion]] | *[[Pulmonary contusion]] | ||
*[[Sepsis]] | *[[Sepsis]] | ||
*[[Severe acute respiratory syndrome]] | *[[Severe acute respiratory syndrome|Severe acute respiratory syndrome (SARS)]] | ||
*[[Sorafenib]] | *[[Sorafenib]] | ||
*[[Physical trauma|Severe trauma]] | *[[Physical trauma|Severe trauma]] | ||
*[[Stevens-Johnson syndrome]] | |||
*[[Burn|Surface burns]] | *[[Burn|Surface burns]] | ||
*[[Tbo-filgrastim]] | |||
*[[Toxic epidermal necrolysis]] | |||
*[[Traumatic brain injury|Traumatic brain injury (TBI)]] | |||
*[[Uremia]] | *[[Uremia]] | ||
*[[ | *[[Urofollitropin]] | ||
{{col-end}} | {{col-end}} | ||
==References== | ==References== | ||
{{reflist|2}} | |||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
Latest revision as of 17:02, 14 July 2016
Acute respiratory distress syndrome Microchapters |
Differentiating Acute respiratory distress syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acute respiratory distress syndrome causes On the Web |
American Roentgen Ray Society Images of Acute respiratory distress syndrome causes |
Directions to Hospitals Treating Acute respiratory distress syndrome |
Risk calculators and risk factors for Acute respiratory distress syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2], Brian Shaller, M.D. [3]
Overview
ARDS may be caused by either direct or indirect insults to the lung. Common causes of ARDS include pneumonia, sepsis, aspiration of gastric contents, and transfusion-related acute lung injury (TRALI).
Causes
Life Threatening Causes
ARDS is a life-threatening condition and must be treated as such irrespective of the causes. Life-threatening conditions may result in death or permanent disability within 24 hours if left untreated.
Common Causes
ARDS may occur as the result of either a direct or indirect insult to the lungs:[1][2][3][4][5]
- Direct insult
- Pneumonia (bacterial, viral, fungal, or parasitic)
- Aspiration of of gastric contents
- Inhalational injury (e.g., smoke inhalation, toxic gas inhalation)
- Fat embolism
- Amniotic fluid embolism
- Drowning
- Pulmonary contusion
- Alveolar hemorrhage
- Reperfusion (pleural effusion drainage, embolectomy)
- Lung transplantation
- Ventilator-associated lung injury
- Indirect insult:
- Severe sepsis
- Major trauma (e.g., head trauma, polytrauma)
- Multiple transfusions or transfusion-associated acute lung injury (TRALI)
- Drug overdose (e.g., acetylsalicylic acid overdose, heroin overdose)
- Pancreatitis
- Severe burns
- Shock
- Cardiopulmonary bypass
- Disseminated intravascular coagulation
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ (1982). "Clinical predictors of the adult respiratory distress syndrome". Am J Surg. 144 (1): 124–30. PMID 7091520.
- ↑ The ARDS Definition Task Force*. “Acute Respiratory Distress Syndrome: The Berlin Definition.” JAMA 307, no. 23 (June 20, 2012): 2526–33. doi:10.1001/jama.2012.5669.
- ↑ Wheeler, Arthur P., and Gordon R. Bernard. “Acute Lung Injury and the Acute Respiratory Distress Syndrome: A Clinical Review.” Lancet (London, England) 369, no. 9572 (May 5, 2007): 1553–64. doi:10.1016/S0140-6736(07)60604-7.
- ↑ Sweeney, Rob Mac, and Daniel F. McAuley. “Acute Respiratory Distress Syndrome.” Lancet (London, England), April 28, 2016. doi:10.1016/S0140-6736(16)00578-X.
- ↑ Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Baird, D. J. Eberle, T. L. Petty, and T. M. Hyers. “Adult Respiratory Distress Syndrome: Risk with Common Predispositions.” Annals of Internal Medicine 98, no. 5 Pt 1 (May 1983): 593–97.
- ↑ de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Van Nhieu JT, Duong TA, Chosidow O; et al. (2014). "Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation". Crit Care Med. 42 (1): 118–28. doi:10.1097/CCM.0b013e31829eb94f. PMID 23989174.